| | | |  | Keep up with all the developments at the 2022 American Society of Hematology meeting with our ASH in 30 pop-up newsletter, written by STAT's Angus Chen, Adam Feuerstein, and Damian Garde. Sign up to get the first edition tomorrow. | | | | By Ed Silverman Milken Institute "I’m sorry, but think about how ludicrous your point is," Regeneron president George Yancopoulos said to the panel moderator. Read More | | By Michael Elashoff Adobe Health AI sits between health care and tech. Like the border between two nations, there are significant differences on either side. Read More | | By Mohana Ravindranath Milken Institute Technology can exacerbate health care disparities, or it can start to close gaps in access. Here's what can make the difference. Read More | | Sponsored Insight by Organon This is the decade of biosimilar market growth As inflation continues to climb, it's more critical than ever to help reduce costs on the health care system and increase competition in biologic medicines. With so many biologic medications expected to come off patent, additional biosimilar medications may be developed. This new era of biosimilar competition may improve medication access. Read more about a future with biosimilars. | | By Ambar Castillo Milken Institute At the root of the diversity crisis in dentistry are factors such as underserved communities' lack of access to dental care. Read More | |
No comments